Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
3(33%)
Results Posted
20%(1 trials)

Phase Distribution

Ph phase_3
2
22%
Ph not_applicable
1
11%
Ph phase_2
1
11%
Ph phase_4
3
33%

Phase Distribution

0

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
2(28.6%)
Phase 4Post-market surveillance
3(42.9%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

9

all time

Status Distribution
Active(4)
Completed(5)

Detailed Status

Completed5
Recruiting3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (14.3%)
Phase 32 (28.6%)
Phase 43 (42.9%)
N/A1 (14.3%)

Trials by Status

recruiting333%
completed556%
not_yet_recruiting111%

Recent Activity

3 active trials
Showing 5 of 9
not_yet_recruiting

Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study

NCT07262710
recruitingphase_4

Angiotensin Receptor Blockers in Aortic Stenosis

NCT04913870
recruitingphase_3

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

NCT02735707
completed

ARB, ACEi, DRi Effects on COVID-19 Course Disease

NCT04364984
completedphase_4

Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease

NCT04394117
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT07262710

Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study

Not Yet Recruiting
NCT04913870Phase 4

Angiotensin Receptor Blockers in Aortic Stenosis

Recruiting
NCT02735707Phase 3

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Recruiting
NCT04364984

ARB, ACEi, DRi Effects on COVID-19 Course Disease

Completed
NCT04394117Phase 4

Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease

Completed
NCT05232370Phase 2

The Effect of Enalapril, Losartan or Not Antihypertensive on the Oxidative Status in Renal Transplant Recipients

Completed
NCT03770702Phase 3

Statins and ARBs on Rheumatoid Activity

Recruiting
NCT00224809Not Applicable

Impact of Medical and Surgical Therapy on Functional Mitral Regurgitation

Completed
NCT00135551Phase 4

Benidipine-based Comparison of Angiotensin Receptors, β-blockers, or Thiazide Diuretics in Hypertensive Patients

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9